Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603719.pdf
Reference40 articles.
1. Altman D, De Stavola B, Love S, Stepniewska K (1995) Review of survival analysis published in cancer journals. Br J Cancer 72: 511–518
2. American Cancer Society (2003) Cancer Facts and Figures 2003. American Cancer Society: Atlanta
3. Banu E, Oudard S, Banu A, Fodor A, Landi B, Lecomte T, Laurent-Puig P, Cugnenc PJ, Andrieu JM (2005) Cumulative meta-analysis of randomised trials comparing gemcitabine-based chemotherapy vs gemcitabine alone in patients with advanced or metastatic pancreatic cancer. In ASCO Annual Meeting, abstract no. 4101, Orlando, USA
4. Bria E, Carlini P, Gelibter A, Ruggeri E, Ceribelli A, Pino M, Terzoli E, Cognetti F, Giannarelli D, Milella M (2006) Current status of targeted agents in advanced pancreatic cancer (APC): A pooled analysis of 2,361 patients (pts) enrolled in six phase III trials. J Clin Oncol 24: 4126
5. Cardenes H, Chiorean E, DeWitt J, Schmidt M, Loehrer P (2006) Locally advanced pancreatic cancer: Current therapeutic approach. Oncologist 11: 612–623
Cited by 207 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes After Multimodality Treatment of Pancreatic Cancer in an Unselected Single-Center Cohort;Cancer Management and Research;2024-08
2. AMPK phosphorylation of FNIP1 (S220) controls mitochondrial function and muscle fuel utilization during exercise;Science Advances;2024-02-09
3. Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells;Science Advances;2024-02-09
4. Effect of First-line Chemotherapy Alone Versus First-line Chemotherapy Plus Radiotherapy on Survival in Patients with Locally Advanced Pancreatic Cancer in the IMRT era: A Retrospective Cohort Study;2023-12-12
5. Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials;Current Oncology;2023-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3